Photo Release — Medical Marijuana, Inc.’s RSHO(TM) Appears in Wall Street Journal Article About New York Medical Marijuana Licenses
MJNA’s Flagship Product Real Scientific Hemp Oil(TM) Placed as Top Photo in the Nation’s Most Respected Business Publication
Medical Marijuana, Inc. (OTC Pink:MJNA) is pleased that its flagship cannabidiol (CBD) hemp oil brand, Real Scientific Hemp Oil(TM) (RSHO(TM)) appeared in the Wall Street Journalon July 31st 2015, as part of the paper’s coverage of New York State medical marijuana license recipients.
A photo accompanying this release is available athttps://www.globenewswire.com/newsroom/prs/?pkgid=34911
“We are honored and excited to see our flagship product Real Scientific Hemp Oil(TM) appearing in coverage from the Wall Street Journal,” states Dr. Stuart Titus, the CEO of Medical Marijuana, Inc. “The mainstream media is finally taking notice of the wonderful impact that RSHO(TM) had for the people of Brazil.”
The Wall Street Journal article that showed RSHO(TM) was centered on the closely watched application process in New York State. The article included coverage of the five companies that were awarded state medical marijuana licenses on July 31.
“We congratulate and applaud the New York State legislators and officials who helped push through this important state program to help so many people in need in the Empire State,” Titus says. “New York has developed a very progressive medical marijuana program and will not include smokable products. In New York, extracts including oils and tinctures will be allowed for patients as will other more socially acceptable forms of delivery.”
Real Scientific Hemp Oil(TM) was photographed by Getty Images at the International Cannabis Association’s Cannabis World Congress and Business Expo, held in New York City on June 17-19. News about RSHO(TM)’s impact on the nation of Brazil, the eighth-largest economy in the world, drove significant media attention to RSHO(TM) at the New York show.
Latest news and updates concerning RSHO(TM) and Brazil include the fact that RSHO(TM) is now being used by 800 families in Brazil, and the government of Brazil dropping up to 60 percent of the import tax on RSHO(TM). All of this transpired, of course, after the government of Brazil approved Medical Marijuana, Inc.’s new partner HempMeds Brasil(TM) and their products as a prescription medication for import.
“With Real Scientific Hemp Oil(TM) changing the lives of so many people around the world, we are confident that shareholders and the general public will be hearing much more about RSHO(TM) from the mainstream news media in the coming weeks and months,” Titus states. “HempMedsTM has many years of experience with these extracts and developing tinctures of CBD Hemp Oil. While many patients in New York will have to wait many months for their State-approved meds – hemp-based CBD products are available today for health and wellness benefits.”
About Medical Marijuana, Inc.
Our mission is to be the premier hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:www.MedicalMarijuanaInc.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
FORWARD-LOOKING DISCLAIMER
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
LEGAL DISCLOSURE
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of hemp-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
For further information, please contact: Public Relations contact: Andrew Hard Spokesperson CMW Media P. 858-380-5478 andrew.hard@cmwmedia.com Corporate contact: Medical Marijuana, Inc. Toll Free: 888-OTC-MJNA (888-682-6562) www.medicalmarijuanainc.com www.facebook.com/mjnainc Investor Relations: GH Investment Advisors 550 West "C" Street, Ste. 2040 San Diego, CA 92101 Nick Massalas Office: (858) 264-6500 Toll Free: (877) 964-6463 info@ghinvestmentadvisors.com
MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
